Skip to main content
Top

2012 | OriginalPaper | Hoofdstuk

19 Neuromusculaire aandoeningen bij kinderen: veranderende perspectieven

Recente inzichten en ontwikkelingen in de fysiotherapie

Auteurs : Anton Comuth, Merel Jansen, Imelda de Groot

Gepubliceerd in: Jaarboek Fysiotherapie Kinesitherapie 2012

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

» Neuromusculaire aandoeningen (NMA) zijn aandoeningen van de zenuwen, de spier-zenuwovergangen en de spieren. Zij kennen verschillen in uitingsvorm, overerving, lokalisatie (neurogeen/musculair), zijn progressief of stationair en kunnen verschillen per leeftijdscategorie. Genezing is doorgaans niet mogelijk en daarom wordt vooral symptomatisch behandeld met onder andere fysiotherapie. De levensverwachting van kinderen met een neuromusculaire aandoening neemt toe en daarmee verschuift ook de nadruk van de fysiotherapeutische aanpak. Voor de kinderfysiotherapie ligt er nu meer nadruk op preventie of sturen van contractuurvorming, onderhoud van functionele mogelijkheden en verbeteren van de hart-longconditie. Ook is het van toenemend belang om meetinstrumenten te hanteren, om de effectiviteit van behandelingen in de loop van de tijd te evalueren.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference American Thoracic Society Documents. Respiratory care of the patient with Duchenne muscular dystrophy. ATS Consensus Statement; 2004. American Thoracic Society Documents. Respiratory care of the patient with Duchenne muscular dystrophy. ATS Consensus Statement; 2004.
go back to reference Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve. 2007;36(4):424-35. Angelini C. The role of corticosteroids in muscular dystrophy: a critical appraisal. Muscle Nerve. 2007;36(4):424-35.
go back to reference Bakker JPJ, Groot IJM de, Beckerman H, Jong BA de, Lankhorst GJ. The effects of knee-ankle foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clin Rehabil. 2000;14(4):343-59. Bakker JPJ, Groot IJM de, Beckerman H, Jong BA de, Lankhorst GJ. The effects of knee-ankle foot orthoses in the treatment of Duchenne muscular dystrophy: review of the literature. Clin Rehabil. 2000;14(4):343-59.
go back to reference Beld WA. Muscle strength testing in children, development and evaluation of a motor performance test for myopathy; 2006. Beld WA. Muscle strength testing in children, development and evaluation of a motor performance test for myopathy; 2006.
go back to reference Berard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463-70. Berard C, Payan C, Hodgkinson I, Fermanian J. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005;15(7):463-70.
go back to reference Birnkrant D J, Bushby K, Amin RS. The Respiratory Management of patients with Duchenne Muscular Dystrophy: ADMD Care Considerations Working Group Specialty Article; 2010. Birnkrant D J, Bushby K, Amin RS. The Respiratory Management of patients with Duchenne Muscular Dystrophy: ADMD Care Considerations Working Group Specialty Article; 2010.
go back to reference Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186-97. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981;4(3):186-97.
go back to reference Bushby K, Bourkeb J, Bullockc R. The multidisciplinary management of Duchenne muscular dystrophy. Current Paediatrics 2005;15:292-300. Bushby K, Bourkeb J, Bullockc R. The multidisciplinary management of Duchenne muscular dystrophy. Current Paediatrics 2005;15:292-300.
go back to reference Bushby K, Finkel R, Birnkrant DJ. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. www.thelancet.com/neurology Published Online November 30, 2009 DOI:10.1016/S1474-4422(09)70271-6. Bushby K, Finkel R, Birnkrant DJ. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. www.​thelancet.​com/​neurology Published Online November 30, 2009 DOI:10.1016/S1474-4422(09)70271-6.
go back to reference Bushby K, Finkel R, Birnkrant DJ. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. www.thelancet.com/neurology Published Online November 30, 2009 DOI:10.1016/S1474-4422(09)70272-8. Bushby K, Finkel R, Birnkrant DJ. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. www.​thelancet.​com/​neurology Published Online November 30, 2009 DOI:10.1016/S1474-4422(09)70272-8.
go back to reference Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord. 2002;12(10):975-83. Eagle M. Report on the muscular dystrophy campaign workshop: exercise in neuromuscular diseases Newcastle, January 2002. Neuromuscul Disord. 2002;12(10):975-83.
go back to reference Kang SW, Bach JR. Maximum insufflation capacity. Chest. 2000;118:61-65. Kang SW, Bach JR. Maximum insufflation capacity. Chest. 2000;118:61-65.
go back to reference Mazzone ES, Messina S, Vasco G et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord. 2009;19(7):458-61. Mazzone ES, Messina S, Vasco G et al. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord. 2009;19(7):458-61.
go back to reference McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11Suppl):S108-S120. McDonald CM. Physical activity, health impairments, and disability in neuromuscular disease. Am J Phys Med Rehabil. 2002;81(11Suppl):S108-S120.
go back to reference McDonald CM. The six minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle & Nerve. 2009;April. McDonald CM. The six minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle & Nerve. 2009;April.
go back to reference Rose KJ, Burns J, Wheeler DM. Interventions for increasing ankle range of motion in patients with neuromuscular disease. The Cochrane Collaboration. Wiley & Sons, Ltd.; 2010. Rose KJ, Burns J, Wheeler DM. Interventions for increasing ankle range of motion in patients with neuromuscular disease. The Cochrane Collaboration. Wiley & Sons, Ltd.; 2010.
go back to reference Rothstein JM, Echternach JL, Riddle DL. The hypothesis-oriented algorithm for clinicians II (HOAC II). A guide for patient management. Phys Ther. 2003;83(5). Rothstein JM, Echternach JL, Riddle DL. The hypothesis-oriented algorithm for clinicians II (HOAC II). A guide for patient management. Phys Ther. 2003;83(5).
go back to reference Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5(4):291-301. Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve. 1982;5(4):291-301.
go back to reference Smits-Engelsman BCM, Galen GP van, Hulstijn W. Motorisch onderzoek door de fysiotherapeut: het belang van proces georiënteerd, kwantitatief en kwalitatief motorisch onderzoek. In: Vaes, P, et al (red.), Jaarboek Fysiotherapie Kinesitherapie 1997. Houten: Bohn Stafleu van Loghum; 1997, 200-221. Smits-Engelsman BCM, Galen GP van, Hulstijn W. Motorisch onderzoek door de fysiotherapeut: het belang van proces georiënteerd, kwantitatief en kwalitatief motorisch onderzoek. In: Vaes, P, et al (red.), Jaarboek Fysiotherapie Kinesitherapie 1997. Houten: Bohn Stafleu van Loghum; 1997, 200-221.
go back to reference Steffensen B, Hyde S, Lyager S, Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int. 2001;6(3):119-34. Steffensen B, Hyde S, Lyager S, Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int. 2001;6(3):119-34.
go back to reference Voet NB, Kooi EL van der, Riphagen II. Strength training and aerobic exercise training for muscle disease. Cochrane Syst Rev 2010; (1):CD003907). Voet NB, Kooi EL van der, Riphagen II. Strength training and aerobic exercise training for muscle disease. Cochrane Syst Rev 2010; (1):CD003907).
go back to reference VSCA. Behandelrichtlijn scoliose bij neuromusculaire aandoeningen. Vereniging Samenwerkingsverband Chronische Ademhalingsondersteuning; 2007. VSCA. Behandelrichtlijn scoliose bij neuromusculaire aandoeningen. Vereniging Samenwerkingsverband Chronische Ademhalingsondersteuning; 2007.
go back to reference Westermann EJA. Long volume recrutering: respiratoire preventie door de revalidatiearts. Revalidata. 2009;147:18-20. Westermann EJA. Long volume recrutering: respiratoire preventie door de revalidatiearts. Revalidata. 2009;147:18-20.
go back to reference Williams PE, Goldspink G. The effect of denervation and dystrophy on the adaptation of sarcomere number to the functional length of muscle in young and adult mice. J Anat. 1976;122:455-465. Williams PE, Goldspink G. The effect of denervation and dystrophy on the adaptation of sarcomere number to the functional length of muscle in young and adult mice. J Anat. 1976;122:455-465.
Metagegevens
Titel
19 Neuromusculaire aandoeningen bij kinderen: veranderende perspectieven
Auteurs
Anton Comuth
Merel Jansen
Imelda de Groot
Copyright
2012
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-8756-4_19